School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
MRC Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom.
mBio. 2024 Aug 14;15(8):e0151224. doi: 10.1128/mbio.01512-24. Epub 2024 Jul 22.
produces a plethora of virulence factors critical to its ability to establish an infection and cause disease. We have previously characterized a small membrane protein, MspA, which has pleiotropic effects on virulence and contributes to pathogenicity . Here we report that inactivation triggers overaccumulation of the essential cell wall component, lipoteichoic acid (LTA), which, in turn, decreases autolytic activity and leads to increased cell size due to a delay in cell separation. We show that MspA directly interacts with the enzymes involved in LTA biosynthesis (LtaA, LtaS, UgtP, and SpsB), interfering with their normal activities. MspA, in particular, interacts with the type I signal peptidase SpsB, limiting its cleavage of LtaS into its active form. These findings suggest that MspA contributes to maintaining a physiological level of LTA in the cell wall by interacting with and inhibiting the activity of SpsB, thereby uncovering a critical role for the MspA protein in regulating cell envelope biosynthesis and pathogenicity.IMPORTANCEThe cell envelope, comprising the cytoplasmic membrane, a thick peptidoglycan layer, and the anionic polymers lipoteichoic acid and wall teichoic acids, is fundamental for bacterial growth and division, as well as being the main interface between the pathogen and the host. It has become increasingly apparent that the synthesis and turnover of cell envelope components also affect the virulence of . In this study, we show that MspA, an effector of virulence, contributes to the maintenance of normal levels of lipoteichoic acid in the cell wall, with implications on cell cycle and size. These findings further our understanding of the connections between envelope synthesis and pathogenicity and suggest that MspA represents a promising target for the development of future therapeutic strategies.
产生大量毒力因子,这些因子对其建立感染和引起疾病的能力至关重要。我们之前已经对一种小膜蛋白 MspA 进行了特征描述,该蛋白对毒力具有多种影响,并有助于致病性。在这里,我们报告说失活会触发必需细胞壁成分脂磷壁酸(LTA)的过度积累,反过来又会降低自溶活性,并由于细胞分离延迟而导致细胞尺寸增大。我们表明 MspA 直接与参与 LTA 生物合成的酶(LtaA、LtaS、UgtP 和 SpsB)相互作用,干扰其正常活性。MspA 特别与 I 型信号肽酶 SpsB 相互作用,限制其将 LtaS 切割成其活性形式。这些发现表明,MspA 通过与 SpsB 相互作用并抑制其活性来维持细胞壁中 LTA 的生理水平,从而揭示了 MspA 蛋白在调节细胞包膜生物合成和致病性方面的关键作用。
重要性细胞包膜由细胞质膜、厚肽聚糖层以及阴离子聚合物脂磷壁酸和壁磷壁酸组成,是细菌生长和分裂的基础,也是病原体与宿主之间的主要界面。越来越明显的是,细胞包膜成分的合成和周转也会影响毒力。在这项研究中,我们表明,毒力效应子 MspA 有助于维持细胞壁中脂磷壁酸的正常水平,这对细胞周期和大小有影响。这些发现进一步加深了我们对包膜合成与致病性之间联系的理解,并表明 MspA 代表了开发未来治疗策略的有前途的靶标。